Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic
Status:
COMPLETED
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
Objective: To compare the efficacy, safety, and recurrence rates of topical salicylic acid/lactic acid (SA/LA) monotherapy (Group A), intralesional Candida antigen (CA) monotherapy (Group B), and their combination (Group C) for the treatment of warts.